{
  "DOI": "10.1186/s40246-019-0197-3",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-019-0197-3",
  "alternative-id": [
    "197"
  ],
  "article-number": "13",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "15 November 2018"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "17 February 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "22 February 2019"
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "This study was approved by Universiti Putra Malaysia (UPM), Universiti Kebangsaan Malaysia (UKM) ethics committee and Medical Research Ethics Committee (MREC), Ministry of Health, Malaysia (MOH). This study was registered with the National Medical Research Registry with the registration number NMRR-14-1176-21475."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors declare that they have no competing interests."
    },
    {
      "group": {
        "label": "Publisher’s Note",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Mohamad",
      "given": "Nur Afiqah",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Ramachandran",
      "given": "Vasudevan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Mohd Isa",
      "given": "Hazlita",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Chan",
      "given": "Yoke Mun",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ngah",
      "given": "Nor Fariza",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ching",
      "given": "Siew Mooi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hoo",
      "given": "Fan Kee",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wan Sulaiman",
      "given": "Wan Aliaa",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Inche Mat",
      "given": "Liyana Najwa",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Mohamed",
      "given": "Mohd Hazmi",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2019,
        2,
        22
      ]
    ],
    "date-time": "2019-02-22T13:02:51Z",
    "timestamp": 1550840571000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        11,
        28
      ]
    ],
    "date-time": "2020-11-28T11:04:59Z",
    "timestamp": 1606561499000
  },
  "funder": [
    {
      "DOI": "10.13039/501100004530",
      "award": [
        "9409800",
        "9432700"
      ],
      "doi-asserted-by": "publisher",
      "name": "Universiti Putra Malaysia"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        5
      ]
    ],
    "date-time": "2024-03-05T22:03:07Z",
    "timestamp": 1709676187895
  },
  "is-referenced-by-count": 16,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2019,
        2,
        22
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2019,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2019,
            2,
            22
          ]
        ],
        "date-time": "2019-02-22T00:00:00Z",
        "timestamp": 1550793600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-019-0197-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1186/s40246-019-0197-3/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-019-0197-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2019,
        2,
        22
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2019,
        2,
        22
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2019,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/S0140-6736(12)60282-7",
      "author": "LS Lim",
      "doi-asserted-by": "publisher",
      "first-page": "1728",
      "journal-title": "Lancet.",
      "key": "197_CR1",
      "unstructured": "Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012;379:1728–38.",
      "volume": "379",
      "year": "2012"
    },
    {
      "DOI": "10.1155/2013/895147",
      "author": "S Velilla",
      "doi-asserted-by": "crossref",
      "first-page": "895147",
      "journal-title": "J Ophthalmol",
      "key": "197_CR2",
      "unstructured": "Velilla S, Garcia-Medina JJ, Garcia-Layana A, Dolz-Marco R, Pons-Vazquez S, Pinazo-Duran MD, et al. Smoking and age-related macular degeneration: review and update. J Ophthalmol. 2013;2013:895147.",
      "volume": "2013",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.preteyeres.2016.04.003",
      "author": "NG Lambert",
      "doi-asserted-by": "publisher",
      "first-page": "64",
      "journal-title": "Prog Retin Eye Res",
      "key": "197_CR3",
      "unstructured": "Lambert NG, ElShelmani H, Singh MK, Mansergh FC, Wride MA, Padilla M, et al. Risk factors and biomarkers of age-related macular degeneration. Prog Retin Eye Res. 2016;54:64–102.",
      "volume": "54",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ophtha.2009.04.017",
      "author": "M Yasuda",
      "doi-asserted-by": "publisher",
      "first-page": "2135",
      "journal-title": "Ophthalmology.",
      "key": "197_CR4",
      "unstructured": "Yasuda M, Kiyohara Y, Hata Y, Arakawa S, Yonemoto K, Doi Y, et al. Nine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population the Hisayama study. Ophthalmology. 2009;116:2135–40.",
      "volume": "116",
      "year": "2009"
    },
    {
      "DOI": "10.1038/srep41386",
      "author": "CM Cheung",
      "doi-asserted-by": "publisher",
      "first-page": "41386",
      "journal-title": "Sci Rep",
      "key": "197_CR5",
      "unstructured": "Cheung CM, Laude A, Yeo I, Tan SP, Fan Q, Mathur R, et al. Systemic, ocular and genetic risk factors for age-related macular degeneration and polypoidal choroidal vasculopathy in Singaporeans. Sci Rep. 2017;7:41386.",
      "volume": "7",
      "year": "2017"
    },
    {
      "author": "I Chowers",
      "first-page": "2263",
      "journal-title": "Mol Vis",
      "key": "197_CR6",
      "unstructured": "Chowers I, Meir T, Lederman M, Goldenberg-Cohen N, Cohen Y, Banin E, et al. Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel. Mol Vis. 2008;14:2263–71.",
      "volume": "14",
      "year": "2008"
    },
    {
      "author": "F Cruz-Gonzalez",
      "first-page": "1304",
      "journal-title": "Int J Ophthalmol",
      "key": "197_CR7",
      "unstructured": "Cruz-Gonzalez F, Cabrillo-Estevez L, Rivero-Gutierrez V, Sanchez-Jara A, De Juan-Marcos L, Gonzalez-Sarmiento R. Influence of CFH, HTRA1 and ARMS2 polymorphisms in the response to intravitreal ranibizumab treatment for wet age-related macular degeneration in a Spanish population. Int J Ophthalmol. 2016;9:1304–9.",
      "volume": "9",
      "year": "2016"
    },
    {
      "DOI": "10.1167/iovs.11-8135",
      "author": "XY Liang",
      "doi-asserted-by": "publisher",
      "first-page": "3175",
      "journal-title": "Invest Ophthalmol Vis Sci",
      "key": "197_CR8",
      "unstructured": "Liang XY, Lai TY, Liu DT, Fan AH, Chen LJ, Tam PO, et al. Differentiation of exudative age-related macular degeneration and polypoidal choroidal vasculopathy in the ARMS2/HTRA1 locus. Invest Ophthalmol Vis Sci. 2012;53:3175–82.",
      "volume": "53",
      "year": "2012"
    },
    {
      "DOI": "10.1126/science.1133807",
      "author": "A Dewan",
      "doi-asserted-by": "publisher",
      "first-page": "989",
      "journal-title": "Science.",
      "key": "197_CR9",
      "unstructured": "Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, Zhao C, et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science. 2006;314:989–92.",
      "volume": "314",
      "year": "2006"
    },
    {
      "DOI": "10.1126/science.1133811",
      "author": "Z Yang",
      "doi-asserted-by": "publisher",
      "first-page": "992",
      "journal-title": "Science.",
      "key": "197_CR10",
      "unstructured": "Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science. 2006;314:992–3.",
      "volume": "314",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.exer.2013.04.019",
      "author": "G Wang",
      "doi-asserted-by": "publisher",
      "first-page": "102",
      "journal-title": "Exp Eye Res",
      "key": "197_CR11",
      "unstructured": "Wang G, Dubovy SR, Kovach JL, Schwartz SG, Agarwal A, Scott WK, et al. Variants at chromosome 10q26 locus and the expression of HTRA1 in the retina. Exp Eye Res. 2013;112:102–5.",
      "volume": "112",
      "year": "2013"
    },
    {
      "DOI": "10.1167/iovs.16-20922",
      "author": "GM Tosi",
      "doi-asserted-by": "publisher",
      "first-page": "162",
      "journal-title": "Invest Ophthalmol Vis Sci",
      "key": "197_CR12",
      "unstructured": "Tosi GM, Caldi E, Neri G, Nuti E, Marigliani D, Baiocchi S, et al. HTRA1 and TGF-beta1 concentrations in the aqueous humor of patients with neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci. 2017;58:162–7.",
      "volume": "58",
      "year": "2017"
    },
    {
      "DOI": "10.1073/pnas.0703933104",
      "author": "A Kanda",
      "doi-asserted-by": "publisher",
      "first-page": "16227",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "197_CR13",
      "unstructured": "Kanda A, Chen W, Othman M, Branham KE, Brooks M, Khanna R, et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci U S A. 2007;104:16227–32.",
      "volume": "104",
      "year": "2007"
    },
    {
      "DOI": "10.1002/14651858.CD011230",
      "doi-asserted-by": "crossref",
      "key": "197_CR14",
      "unstructured": "Moja L, Lucenteforte E, Kwag KH, Bertele V, Campomori A, Chakravarthy U, et al. Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2014;9:CD011230."
    },
    {
      "DOI": "10.1002/14651858.CD005139.pub3",
      "doi-asserted-by": "crossref",
      "key": "197_CR15",
      "unstructured": "Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2014;8:CD005139."
    },
    {
      "author": "J Ba",
      "first-page": "5397",
      "journal-title": "Drug Des Devel Ther",
      "key": "197_CR16",
      "unstructured": "Ba J, Peng RS, Xu D, Li YH, Shi H, Wang Q, et al. Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis. Drug Des Devel Ther. 2015;9:5397–405.",
      "volume": "9",
      "year": "2015"
    },
    {
      "author": "UC Park",
      "first-page": "1680",
      "journal-title": "Mol Vis",
      "key": "197_CR17",
      "unstructured": "Park UC, Shin JY, McCarthy LC, Kim SJ, Park JH, Chung H, et al. Pharmacogenetic associations with long-term response to anti-vascular endothelial growth factor treatment in neovascular AMD patients. Mol Vis. 2014;20:1680–94.",
      "volume": "20",
      "year": "2014"
    },
    {
      "DOI": "10.1167/iovs.10-6080",
      "author": "B Kloeckener-Gruissem",
      "doi-asserted-by": "publisher",
      "first-page": "4694",
      "journal-title": "Invest Ophthalmol Vis Sci",
      "key": "197_CR18",
      "unstructured": "Kloeckener-Gruissem B, Barthelmes D, Labs S, Schindler C, Kurz-Levin M, Michels S, et al. Genetic association with response to intravitreal ranibizumab in patients with neovascular AMD. Invest Ophthalmol Vis Sci. 2011;52:4694–702.",
      "volume": "52",
      "year": "2011"
    },
    {
      "author": "Y Xu",
      "first-page": "1373",
      "journal-title": "Mol Vis",
      "key": "197_CR19",
      "unstructured": "Xu Y, Guan N, Xu J, Yang X, Ma K, Zhou H, et al. Association of CFH, LOC387715, and HTRA1 polymorphisms with exudative age-related macular degeneration in a northern Chinese population. Mol Vis. 2008;14:1373–81.",
      "volume": "14",
      "year": "2008"
    },
    {
      "DOI": "10.1111/cge.12206",
      "author": "R Ratnapriya",
      "doi-asserted-by": "publisher",
      "first-page": "160",
      "journal-title": "Clin Genet",
      "key": "197_CR20",
      "unstructured": "Ratnapriya R, Chew EY. Age-related macular degeneration-clinical review and genetics update. Clin Genet. 2013;84:160–6.",
      "volume": "84",
      "year": "2013"
    },
    {
      "DOI": "10.1159/000355068",
      "author": "D Yuan",
      "doi-asserted-by": "publisher",
      "first-page": "227",
      "journal-title": "Ophthalmologica.",
      "key": "197_CR21",
      "unstructured": "Yuan D, Liu X, Yuan S, Xie P, Liu Q. Genetic association with response to intravitreal ranibizumab for neovascular age-related macular degeneration in the Han Chinese population. Ophthalmologica. 2013;230:227–32.",
      "volume": "230",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.preteyeres.2008.10.001",
      "author": "X Ding",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Prog Retin Eye Res",
      "key": "197_CR22",
      "unstructured": "Ding X, Patel M, Chan CC. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res. 2009;28:1–18.",
      "volume": "28",
      "year": "2009"
    },
    {
      "DOI": "10.1097/IAE.0b013e31822a2c7c",
      "author": "A Orlin",
      "doi-asserted-by": "publisher",
      "first-page": "4",
      "journal-title": "Retina.",
      "key": "197_CR23",
      "unstructured": "Orlin A, Hadley D, Chang W, Ho AC, Brown G, Kaiser RS, et al. Association between high-risk disease loci and response to anti-vascular endothelial growth factor treatment for wet age-related macular degeneration. Retina. 2012;32:4–9.",
      "volume": "32",
      "year": "2012"
    },
    {
      "DOI": "10.17305/bjbms.2018.2493",
      "author": "NA Mohamad",
      "doi-asserted-by": "crossref",
      "first-page": "260",
      "journal-title": "Bosn J Basic Med Sci.",
      "key": "197_CR24",
      "unstructured": "Mohamad NA, Ramachandran V, Ismail P, Mohd Isa H, Chan YM, Ngah NF, et al. Analysis of the association between CFH Y402H polymorphism and response to intravitreal ranibizumab in patients with neovascular age-related macular degeneration (nAMD). Bosn J Basic Med Sci. 2018;18:260–7.",
      "volume": "18",
      "year": "2018"
    },
    {
      "DOI": "10.1016/S0161-6420(00)00409-7",
      "author": "Age-Related Eye Disease Study Research Group",
      "doi-asserted-by": "publisher",
      "first-page": "2224",
      "journal-title": "Ophthalmology",
      "key": "197_CR25",
      "unstructured": "Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology. 2000;107:2224–32.",
      "volume": "107",
      "year": "2000"
    },
    {
      "DOI": "10.1016/j.ophtha.2008.02.012",
      "author": "R Kawasaki",
      "doi-asserted-by": "publisher",
      "first-page": "1735",
      "journal-title": "Ophthalmology.",
      "key": "197_CR26",
      "unstructured": "Kawasaki R, Wang JJ, Aung T, Tan DT, Mitchell P, Sandar M, et al. Prevalence of age-related macular degeneration in a Malay population: the Singapore Malay Eye Study. Ophthalmology. 2008;115:1735–41.",
      "volume": "115",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.ophtha.2014.02.004",
      "author": "CM Cheung",
      "doi-asserted-by": "publisher",
      "first-page": "1598",
      "journal-title": "Ophthalmology.",
      "key": "197_CR27",
      "unstructured": "Cheung CM, Li X, Cheng CY, Zheng Y, Mitchell P, Wang JJ, et al. Prevalence, racial variations, and risk factors of age-related macular degeneration in Singaporean Chinese, Indians, and Malays. Ophthalmology. 2014;121:1598–603.",
      "volume": "121",
      "year": "2014"
    },
    {
      "author": "NA Mohamad",
      "first-page": "1889",
      "journal-title": "Int J Ophthalmol.",
      "key": "197_CR28",
      "unstructured": "Mohamad NA, Ramachandran V, Ismail P, Mohd Isa H, Chan YM, Ngah NF, et al. Prevalence and treatment patterns of ranibizumab and photodynamic therapy in a tertiary care setting in Malaysia. Int J Ophthalmol. 2017;10:1889–97.",
      "volume": "10",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ophtha.2004.10.047",
      "author": "TE Clemons",
      "doi-asserted-by": "publisher",
      "first-page": "533",
      "journal-title": "Ophthalmology",
      "key": "197_CR29",
      "unstructured": "Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology. 2005;112:533–9.",
      "volume": "112",
      "year": "2005"
    },
    {
      "DOI": "10.1167/iovs.14-16271",
      "author": "ZP Vassilev",
      "doi-asserted-by": "publisher",
      "first-page": "1585",
      "journal-title": "Invest Ophthalmol Vis Sci",
      "key": "197_CR30",
      "unstructured": "Vassilev ZP, Ruigomez A, Soriano-Gabarro M, Garcia Rodriguez LA. Diabetes, cardiovascular morbidity, and risk of age-related macular degeneration in a primary care population. Invest Ophthalmol Vis Sci. 2015;56:1585–92.",
      "volume": "56",
      "year": "2015"
    },
    {
      "DOI": "10.1167/iovs.12-10073",
      "author": "P Sundaresan",
      "doi-asserted-by": "publisher",
      "first-page": "7492",
      "journal-title": "Invest Ophthalmol Vis Sci",
      "key": "197_CR31",
      "unstructured": "Sundaresan P, Vashist P, Ravindran RD, Shanker A, Nitsch D, Nonyane BA, et al. Polymorphisms in ARMS2/HTRA1 and complement genes and age-related macular degeneration in India: findings from the INDEYE study. Invest Ophthalmol Vis Sci. 2012;53:7492–7.",
      "volume": "53",
      "year": "2012"
    },
    {
      "DOI": "10.12659/MSM.882447",
      "author": "SJ Teper",
      "doi-asserted-by": "publisher",
      "first-page": "PR1",
      "journal-title": "Med Sci Monit",
      "key": "197_CR32",
      "unstructured": "Teper SJ, Nowinska A, Wylegala E. A69S and R38X ARMS2 and Y402H CFH gene polymorphisms as risk factors for neovascular age-related macular degeneration in Poland - a brief report. Med Sci Monit. 2012;18:PR1–3.",
      "volume": "18",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.kjms.2017.08.003",
      "author": "NM Bakri",
      "doi-asserted-by": "publisher",
      "first-page": "602",
      "journal-title": "The Kaohsiung J Med Sci",
      "key": "197_CR33",
      "unstructured": "Bakri NM, Ramachandran V, Kee HF, Subrayan V, Isa H, Ngah NF, et al. Association of copy number variations in complement factor H-related genes among age-related macular degenerative subjects. The Kaohsiung J Med Sci. 2017;33:602–8.",
      "volume": "33",
      "year": "2017"
    },
    {
      "DOI": "10.1089/gtmb.2017.0079",
      "author": "NA Mohamad",
      "doi-asserted-by": "publisher",
      "first-page": "600",
      "journal-title": "Genet Test Mol Biomarkers",
      "key": "197_CR34",
      "unstructured": "Mohamad NA, Ramachandran V, Ismail P, Mohd Isa H, Chan YM, Ngah NF, et al. VEGF polymorphisms among neovascular age-related macular degenerative subjects in a multiethnic population. Genet Test Mol Biomarkers. 2017;21:600–7.",
      "volume": "21",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ejmhg.2017.06.003",
      "author": "NA Mohamad",
      "doi-asserted-by": "publisher",
      "first-page": "77",
      "journal-title": "Egypt J Med Hum Genet",
      "key": "197_CR35",
      "unstructured": "Mohamad NA, Ramachandran V, Ismail P, Isa HM, Chan YM, Ngah NF, et al. R102G polymorphism of the complement component 3 gene in Malaysian subjects with neovascular age-related macular degeneration. Egypt J Med Hum Genet. 2017;19:77–81.",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ajo.2015.11.033",
      "author": "AR Shah",
      "doi-asserted-by": "publisher",
      "first-page": "154",
      "journal-title": "Am J Ophthalmol",
      "key": "197_CR36",
      "unstructured": "Shah AR, Williams S, Baumal CR, Rosner B, Duker JS, Seddon JM. Predictors of response to intravitreal anti-vascular endothelial growth factor treatment of age-related macular degeneration. Am J Ophthalmol. 2016;163:154–66 e8.",
      "volume": "163",
      "year": "2016"
    },
    {
      "DOI": "10.1136/bjo.2010.193680",
      "author": "M McKibbin",
      "doi-asserted-by": "publisher",
      "first-page": "208",
      "journal-title": "Br J Ophthalmol",
      "key": "197_CR37",
      "unstructured": "McKibbin M, Ali M, Bansal S, Baxter PD, West K, Williams G, et al. CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration. Br J Ophthalmol. 2012;96:208–12.",
      "volume": "96",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.ophtha.2012.05.040",
      "author": "D Smailhodzic",
      "doi-asserted-by": "publisher",
      "first-page": "2304",
      "journal-title": "Ophthalmology.",
      "key": "197_CR38",
      "unstructured": "Smailhodzic D, Muether PS, Chen J, Kwestro A, Zhang AY, Omar A, et al. Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration. Ophthalmology. 2012;119:2304–11.",
      "volume": "119",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.ophtha.2013.01.014",
      "author": "F Abedi",
      "doi-asserted-by": "publisher",
      "first-page": "1641",
      "journal-title": "Ophthalmology.",
      "key": "197_CR39",
      "unstructured": "Abedi F, Wickremasinghe S, Richardson AJ, Islam AF, Guymer RH, Baird PN. Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration. Ophthalmology. 2013;120:1641–8.",
      "volume": "120",
      "year": "2013"
    },
    {
      "author": "JW Kitchens",
      "first-page": "1987",
      "journal-title": "Clin Ophthalmol",
      "key": "197_CR40",
      "unstructured": "Kitchens JW, Kassem N, Wood W, Stone TW, Isernhagen R, Wood E, et al. A pharmacogenetics study to predict outcome in patients receiving anti-VEGF therapy in age related macular degeneration. Clin Ophthalmol. 2013;7:1987–93.",
      "volume": "7",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.ophtha.2013.07.046",
      "author": "AJ Lotery",
      "doi-asserted-by": "publisher",
      "first-page": "2637",
      "journal-title": "Ophthalmology.",
      "key": "197_CR41",
      "unstructured": "Lotery AJ, Gibson J, Cree AJ, Downes SM, Harding SP, Rogers CA, et al. Pharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the IVAN study. Ophthalmology. 2013;120:2637–43.",
      "volume": "120",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.ophtha.2012.11.037",
      "author": "SA Hagstrom",
      "doi-asserted-by": "publisher",
      "first-page": "593",
      "journal-title": "Ophthalmology.",
      "key": "197_CR42",
      "unstructured": "Hagstrom SA, Ying GS, Pauer GJ, Sturgill-Short GM, Huang J, Callanan DG, et al. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). Ophthalmology. 2013;120:593–9.",
      "volume": "120",
      "year": "2013"
    },
    {
      "DOI": "10.1167/iovs.14-14246",
      "author": "NA Restrepo",
      "doi-asserted-by": "publisher",
      "first-page": "6839",
      "journal-title": "Invest Ophthalmol Vis Sci",
      "key": "197_CR43",
      "unstructured": "Restrepo NA, Spencer KL, Goodloe R, Garrett TA, Heiss G, Buzkova P, et al. Genetic determinants of age-related macular degeneration in diverse populations from the PAGE study. Invest Ophthalmol Vis Sci. 2014;55:6839–50.",
      "volume": "55",
      "year": "2014"
    },
    {
      "DOI": "10.1155/2017/4263017",
      "author": "AC Pedrosa",
      "doi-asserted-by": "crossref",
      "first-page": "4263017",
      "journal-title": "J Ophthalmol",
      "key": "197_CR44",
      "unstructured": "Pedrosa AC, Sousa T, Pinheiro-Costa J, Beato J, Falcao MS, Falcao-Reis F, et al. Treatment of neovascular age-related macular degeneration with anti-VEGF agents: predictive factors of long-term visual outcomes. J Ophthalmol. 2017;2017:4263017.",
      "volume": "2017",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.survophthal.2013.03.009",
      "author": "RP Finger",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Surv Ophthalmol",
      "key": "197_CR45",
      "unstructured": "Finger RP, Wickremasinghe SS, Baird PN, Guymer RH. Predictors of anti-VEGF treatment response in neovascular age-related macular degeneration. Surv Ophthalmol. 2014;59:1–18.",
      "volume": "59",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.ophtha.2006.10.045",
      "author": "DS Boyer",
      "doi-asserted-by": "publisher",
      "first-page": "246",
      "journal-title": "Ophthalmology.",
      "key": "197_CR46",
      "unstructured": "Boyer DS, Antoszyk AN, Awh CC, Bhisitkul RB, Shapiro H, Acharya NR. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2007;114:246–52.",
      "volume": "114",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.ajo.2007.08.012",
      "author": "PK Kaiser",
      "doi-asserted-by": "publisher",
      "first-page": "850",
      "journal-title": "Am J Ophthalmol",
      "key": "197_CR47",
      "unstructured": "Kaiser PK, Brown DM, Zhang K, Hudson HL, Holz FG, Shapiro H, et al. Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol. 2007;144:850–7.",
      "volume": "144",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.ajo.2015.07.034",
      "author": "CD Regillo",
      "doi-asserted-by": "publisher",
      "first-page": "1014",
      "journal-title": "Am J Ophthalmol",
      "key": "197_CR48",
      "unstructured": "Regillo CD, Busbee BG, Ho AC, Ding B, Haskova Z. Baseline predictors of 12-month treatment response to ranibizumab in patients with wet age-related macular degeneration. Am J Ophthalmol. 2015;160:1014–23 e2.",
      "volume": "160",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.ophtha.2013.11.031",
      "author": "Collaborators",
      "doi-asserted-by": "publisher",
      "first-page": "1092",
      "journal-title": "Ophthalmology",
      "key": "197_CR49",
      "unstructured": "Collaborators. The neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections: report 1: visual acuity. Ophthalmology. 2014;121:1092–101.",
      "volume": "121",
      "year": "2014"
    },
    {
      "DOI": "10.3341/kjo.2012.26.6.414",
      "author": "HK Kang",
      "doi-asserted-by": "publisher",
      "first-page": "414",
      "journal-title": "Korean J Ophthalmol",
      "key": "197_CR50",
      "unstructured": "Kang HK, Yoon MH, Lee DH, Chin HS. Pharmacogenetic influence of LOC387715/HTRA1 on the efficacy of bevacizumab treatment for age-related macular degeneration in a Korean population. Korean J Ophthalmol. 2012;26:414–22.",
      "volume": "26",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nprot.2009.38",
      "author": "FH Pettersson",
      "doi-asserted-by": "publisher",
      "first-page": "743",
      "journal-title": "Nat Protoc",
      "key": "197_CR51",
      "unstructured": "Pettersson FH, Anderson CA, Clarke GM, Barrett JC, Cardon LR, Morris AP, et al. Marker selection for genetic case–control association studies. Nat Protoc. 2009;4:743–52.",
      "volume": "4",
      "year": "2009"
    },
    {
      "DOI": "10.1186/1753-6561-3-S7-S41",
      "author": "ME Tabangin",
      "doi-asserted-by": "publisher",
      "first-page": "S41",
      "journal-title": "BMC Proc",
      "key": "197_CR52",
      "unstructured": "Tabangin ME, Woo JG, Martin LJ. The effect of minor allele frequency on the likelihood of obtaining false positives. BMC Proc. 2009;3:S41.",
      "volume": "3",
      "year": "2009"
    }
  ],
  "reference-count": 52,
  "references-count": 52,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-019-0197-3"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Association of HTRA1 and ARMS2 gene polymorphisms with response to intravitreal ranibizumab among neovascular age-related macular degenerative subjects"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "13"
}